88
Views
8
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Metformin therapy in the management of polycystic ovary syndrome: endocrine ,metabolic and reproductive effects

&
Pages 373-380 | Published online: 28 Aug 2009
 

Abstract

Polycystic ovary syndrome (PCOS) is a convergence of multisystem endocrine derangements. Impairment in insulin metabolism is a prominent feature of the syndrome and appears to play a key pathogenetic role precipitating the cascade of other disorders associated with PCOS. Recent studies report that insulin-sensitizing agents ,such as metformin ,reduce hyperinsulinemia ,reverse the endocrinopathy of PCOS and normalize endocrine ,metabolic and reproductive functions ,leading to the resumption of menstrual cyclicity and ovulation. In this review ,we report the most recent evidence regarding metformin usage in women with PCOS.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.